Search

everythinglearnresearchcommunity

for

Search:↓

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Researchers found four genes that could help diagnose severe alopecia areata early.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Mathematical modeling can improve regenerative medicine by predicting biological processes and optimizing therapy development.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Stress can worsen skin conditions by affecting hormone levels and immune response.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Researchers found two new genetic variants linked to Alzheimer's disease.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Rabbit skin analysis showed changes in hair growth and identified miRNAs that may regulate hair follicle development.

Aging skin shows thinner layers, fewer hair follicles, and new biomarkers like increased space between cells and smaller sebaceous glands.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.